Quality & complianceOfficial
FDA lists Class II recall of Victory Medical Center Pharmacy tirzepatide/B6 vials
🇺🇸 FDA enforcement report · Wed 11 Nov 2026
The pharmacy's tirzepatide/B6 multi-dose vial is recalled over a lack of processing controls, with distribution in Colorado, Florida and Texas, according to the FDA enforcement report.
The US Food and Drug Administration has classified a Class II drug recall of TIRZEPATIDE/B6 (MDV) 25MG/10MG/ML 8ML from Victory Medical Center Pharmacy. The entry appears in the agency's enforcement report dated 11 November 2026 under recall number D-0148-2027.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official source: FDA enforcement report ↗
Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.
More Quality & compliance
All →
BfArM publishes urgent field safety notice for Bentley InnoMed's BeFlow Iliac Covered Stent System
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM lists Siemens field safety notice for Dimension Urine Barbiturate Screen assay
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes Medtronic MiniMed urgent field safety notice for MiniMed Go app
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Merit Medical field safety notice for Philips BridgeT Balloon Prep Kit
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM posts Urgent Field Safety Notice for Biomet UK's Avantage Cup Gripper
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026
BfArM publishes InterSystems field safety notice for TrakCare France software
🇩🇪 BfArM field safety notices · Wed 18 Nov 2026